These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18705570)

  • 21. Multiple primary neoplasms at a single institution: differences between synchronous and metachronous neoplasms.
    Aydiner A; Karadeniz A; Uygun K; Tas S; Tas F; Disci R; Topuz E
    Am J Clin Oncol; 2000 Aug; 23(4):364-70. PubMed ID: 10955865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synchronous and metachronous colorectal cancers: distinct disease entities or different disease courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015; 62(138):286-90. PubMed ID: 25916050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The results of modern surgical therapy for multiple primary lung cancers.
    Adebonojo SA; Moritz DM; Danby CA
    Chest; 1997 Sep; 112(3):693-701. PubMed ID: 9315801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synchronous and metachronous bilateral breast cancer: a long-term single-institution experience.
    Díaz R; Munárriz B; Santaballa A; Palomar L; Montalar J
    Med Oncol; 2012 Mar; 29(1):16-24. PubMed ID: 21193967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histo-biological comparative analysis of bilateral breast cancer.
    Baker B; Morcos B; Daoud F; Sughayer M; Shabani H; Salameh H; Almasri M
    Med Oncol; 2013 Dec; 30(4):711. PubMed ID: 24062258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implications of estrogen receptor pattern of both tumors in contralateral breast cancer.
    Sandberg ME; Hartman M; Klevebring D; Eloranta S; Ploner A; Hall P; Czene K
    Breast Cancer Res Treat; 2012 Jul; 134(2):793-800. PubMed ID: 22622811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
    Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
    Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Impact of time of occurrence of liver metastases (synchronous vs. metachronous) on early postoperative outcome and long-term survival of colorectal cancer patients].
    Bova R; Kamphues C; Neuhaus P; Puhl G
    Zentralbl Chir; 2014 Apr; 139(2):220-5. PubMed ID: 23846535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synchronous and metachronous metastatic breast cancer--two incarnations of the same beast?
    Senkus E
    Breast; 2014 Feb; 23(1):1. PubMed ID: 24139069
    [No Abstract]   [Full Text] [Related]  

  • 30. Bilateral cancer of the breast: a review of clinical, histologic, and immunohistologic characteristics.
    Sterns EE; Fletcher WA
    Surgery; 1991 Oct; 110(4):617-22. PubMed ID: 1718048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Properties of Synchronous Versus Metachronous Bilateral Breast Carcinoma with Long Time Follow Up.
    Eliyatkin N; Zengel B; Yagci A; Comut E; Postaci H; Uslu A; Aktas S
    Asian Pac J Cancer Prev; 2015; 16(12):4921-6. PubMed ID: 26163616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour?
    Coradini D; Oriana S; Mariani L; Miceli R; Bresciani G; Marubini E; Di Fronzo G
    Eur J Cancer; 1998 May; 34(6):825-30. PubMed ID: 9797693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral breast cancer.
    Gogas J; Markopoulos C; Skandalakis P; Gogas H
    Am Surg; 1993 Nov; 59(11):733-5. PubMed ID: 8239195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.
    Lavrador JP; Pinto MV; Lemos LM; Ribeiro C; Santos AP
    J Neurooncol; 2018 Jan; 136(1):163-171. PubMed ID: 29119423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral breast carcinoma: clinical characteristics and its impact on survival.
    Vuoto HD; García AM; Candás GB; Zimmermann AG; Uriburu JL; Isetta JA; Cogorno L; Khoury M; Bernabó OL
    Breast J; 2010; 16(6):625-32. PubMed ID: 21070440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Estrogen and progesterone receptor concordance between primary and recurrent breast cancer.
    Li BD; Byskosh A; Molteni A; Duda RB
    J Surg Oncol; 1994 Oct; 57(2):71-7. PubMed ID: 7934066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synchronous and metachronous skeletal osteosarcomas: the Norwegian Radium Hospital experience.
    Brandal P; Bjerkehagen B; Bruland OS; Skjeldal S; Bogsrud TV; Hall KS
    Acta Oncol; 2009; 48(8):1165-72. PubMed ID: 19863225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synchronous and Metachronous Colorectal Cancers: Distinct Disease Entities or Different Disease Courses?
    Huang CS; Yang SH; Lin CC; Lan YT; Chang SC; Wang HS; Chen WS; Lin TC; Lin JK; Jiang JK
    Hepatogastroenterology; 2015 Jun; 62(140):838-42. PubMed ID: 26902012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Women with multiple primary breast cancers diagnosed within a five year period, 1994-1998.
    Howe HL; Weinstein R; Alvi R; Kohler B; Ellison JH
    Breast Cancer Res Treat; 2005 Apr; 90(3):223-32. PubMed ID: 15830135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic disease.
    Potthoff AL; Heimann M; Lehmann F; Ilic I; Paech D; Borger V; Radbruch A; Schäfer N; Schuss P; Vatter H; Herrlinger U; Schneider M
    J Neurooncol; 2023 Feb; 161(3):539-545. PubMed ID: 36695975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.